HomeAmazon launches AI drug discovery platform to tackle research bottlenecks
The platform combines in silico modelling with wet-lab validation in a single system, allowing researchers to design, test and refine drug candidates in shorter cycles.
The platform combines in silico modelling with wet-lab validation in a single system, allowing researchers to design, test and refine drug candidates in shorter cycles.
Disclaimer: This content has been automatically aggregated from Enterprise AI for informational purposes. To read the original article, please visit Enterprise AI.
